Michael A Metzger Syndax Pharmaceuticals Inc (SNDX) insider trading activity

Michael A Metzger is Chief Executive Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 298,661 shares of SNDX, which is worth approximately $4.73 Million. The most recent transaction as insider was on Feb 01, 2021, when has been sold 15,000 shares (Common Stock) at a price of $7.2 per share, resulting in proceeds of $108,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 299K

2.46% 3M change

82.21% 12M change

Total Value Held $4.73 Million

Michael A Metzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2021	BUY Exercise of conversion of derivative security	$108,000 $7.2 p/Share	15,000 Added 31.47%	32,659 Common Stock
Dec 01 2020	SELL Open market or private sale	$344,550 $22.97 p/Share	15,000 Reduced 45.93%	17,659 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$108,000 $7.2 p/Share	15,000 Added 31.47%	32,659 Common Stock
Nov 04 2020	SELL Open market or private sale	$2,031,000 $20.31 p/Share	100,000 Reduced 84.99%	17,659 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$720,000 $7.2 p/Share	100,000 Added 45.94%	117,659 Common Stock

Also insider at

CTIC

CTI BIOPHARMA CORP Healthcare

Director

PYXS

Pyxis Oncology, Inc. Healthcare

MAM